česky | english | Site map

Breast cancer screening in the Czech Republic

The population-based breast screening was officially launched in the Czech Republic in September 2002. It is an open secret, however, that an “opportunistic screening” had already been there before (i.e., preventive examinations of women in some mammography centres at the time of non-existence of official breast screening), whose outcomes have had a significant impact on the interpretation of results of initial stages of the official breast screening.

From the legislative point of view, the project is enshrined in the Decree no. 70/2012 Coll. of MZCR, stipulating the content and intervals of preventive examinations. Specifically, the criteria and conditions for breast screening in the Czech Republic are defined by the Czech Ministry of Health Gazette No. 12/2004.

Council of the European Union - logoThe Breast Cancer Screening Programme in the Czech Republic follows the recommendation of the Council of the European Union from 2nd November 2003 (2003/878/EC; PDF file, 93 kB), stating that all EU members should adopt organised screening programmes for breast cancer, cervical cancer and colorectal cancer. The Council of the European Union recommends the collection of data on preventive examination, subsequent diagnostic procedures and final diagnoses. These data should be used to monitor the screening process and the results should be made available to the public and to health professionals. A detailed recommendation for the implementation of cancer screening programmes in individual EU members is provided in the European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis ( PDF file, 159 kB). Data collection from breast screening in the Czech Republic complies with the recommendation of the Council of the European Union, making it possible to monitor the screening programme in a way compatible with the European Guidelines.

The Breast Cancer Screening Programme currently runs in several dozen accredited screening centres whose functioning is monitored and checked according to transparent rules. The programme course, adherence to the stipulated rules, as well as research activities linked to the project are overseen by two independent committees:

  • Breast Cancer Screening Committee at the Ministry of Health. This Committee involves representatives of breast radiologists, members of Boards of all expert medical societies involved in the diagnosis and treatment of breast diseases, the State Office for Nuclear Safety (SUJB), the General Health Insurance Company (VZP), the Health Insurance Funds (representing other health insurance companies) and the Czech Ministry of Health.
  • Expert Committee on Breast Radiology (KOMD). This Committee involves mainly the representatives of the Czech Radiological Society, the Association of Non-Governmental Radiologists, and the Association of Czech Breast Radiologists (AMA-CZ).

Furthermore, the Association of Czech Breast Radiologists (AMA-CZ) also participates in the organization, management and control of the Breast Cancer Screening Programme in the Czech Republic.

The above-mentioned subjects responsible for the management of screening and diagnosis of breast cancer have agreed with the Czech Ministry of Health to appoint an academic institute responsible for data collection and performance monitoring of the screening programmes through data audit; this role has been attributed to the Institute of Biostatistics and Analyses (IBA) at Masaryk University in Brno, Czech Republic.

IBA is among the largest providers of special-purpose clinical registries in the Czech Republic. It cooperates with many medical societies of the Czech Medical Association, including the Czech Society for Oncology. The data collection process is certified with the ISO 20 000 IT Service Management standards.

Related issues

Last updated on 14 November 2014